MarketPulse

uniQure

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

uniQure Stock Plunges 49% on FDA Gene Therapy Setback; Class Action Lawsuit Filed

$QURE plummeted 49% after FDA feedback on AMT-130 gene therapy. Pomerantz Law Firm filed class action lawsuit; investor deadline April 13, 2026.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Boston Scientific Faces Securities Class Action Over Electrophysiology Misstatements

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability, resulting in earnings miss and weak guidance.
CRWVQUREBSXsecurities fraudclass action lawsuit